Guardant Health and Zephyr AI have partnered to advance the discovery of novel cancer biomarkers, as more precise tumour ...

Guardant Health (Nasdaq: GH), a leading precision oncology company, and Zephyr AI, a leader in precision medicine harnessing ...

Oncology-focused biotech company Guardant Health is partnering with AI drug development company Zephyr AI to combine AI and ...

Annapolis, Maryland – Date: October 6, 2010 – Zephyr Technology, developers of Physiological Status Monitoring (PSM) solutions for First Responders, announce that they have been working with Chilean ...

Guardant Health (GH) and Zephyr AI announced a strategic partnership to insights that support biopharmaceutical innovation. This collaboration will combine multimodal molecular data and AI/ML ...